Intended for healthcare professionals

Latest dermatology news

 

LEO receives FDA approval for Anzupgo cream in chronic hand eczema

Around 70% of patients with severe cases report problems performing everyday activities

31 Jul 2025

Lilly/Almirall’s Ebglyss shows promise in eczema patients with darker skin tones

Approximately 40% of atopic dermatitis patients have moderate or severe symptoms

31 Jul 2025

LEO pays €90m upfront for Boehringer’s generalised pustular psoriasis drug

The company will also have an opportunity to evaluate Spevigo in additional skin conditions

24 Jul 2025

Sanofi/Regeneron receive FDA approval for Dupixent in bullous pemphigoid

The drug is now the only targeted medicine approved in the US to treat the skin disease

24 Jul 2025

Galderma unveils long-term results for Nemluvio in prurigo nodularis

As many as 181,000 people in the US are affected by the chronic skin disorder

17 Jul 2025

FDA approves new presentation of Celltrion’s ustekinumab biosimilar for psoriasis

It is hoped that the approval will support treatment continuity for patients

03 Jul 2025

Boehringer receives NICE recommendation for Spevigo in generalised pustular psoriasis

The decision gives patients access to a therapy that targets the interleukin-36 pathway for the first time

26 Jun 2025

UCB shares three-year results for Bimzelx in psoriatic arthritis

Psoriatic arthritis affects around 30% of psoriasis patients

26 Jun 2025

Sanofi/Regeneron share phase 4 results for Dupixent in atopic dermatitis

The trial has been evaluating the drug in patients with darker skin tones

19 Jun 2025

Galderma’s Nemluvio shows sustained improvements in atopic dermatitis

The long-term study has been evaluating the drug in over 1,900 patients with moderate-to-severe cases

12 Jun 2025
12345678910...